Literature DB >> 20605443

High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study.

Rikje Ruiter1, Loes E Visser, Mark Eijgelsheim, Eline M Rodenburg, Albert Hofman, Jan-Willem W Coebergh, Tamar Nijsten, Bruno H Ch Stricker.   

Abstract

INTRODUCTION: In Caucasians, basal cell carcinoma (BCC) is among the most frequently diagnosed cancers and its incidence is increasing. Known risk factors for the development of BCC are age, sun exposure, and certain skin characteristics. Despite photosensitizing abilities of diuretic agents, little is known about a possible association with BCC.
METHODS: Data were obtained from the Rotterdam Study; a large prospective population-based follow-up study with coverage of prescription-only drugs from pharmacies. The diagnoses of BCC were obtained through general practitioners, and by linkage with a registry of histo- and cytopathology. Cumulative use of diuretics at the date of diagnosis was categorized into quartiles for users of high-ceiling diuretics, potassium sparing agents and thiazides. The association between these drugs and BCC was assessed by Cox proportional hazard modeling with adjustment for age, gender and potential confounders. Effect modification was tested with interaction terms.
RESULTS: Use of high-ceiling diuretics in the highest quartile (>3.7 years cumulative exposure) was associated with an increased hazard of BCC of 62% compared to no use (HR 1.6; 95% CI 1.1-2.4). Patients who used high-ceiling diuretics and had a high tendency of getting sunburned had a higher risk of diagnosis than non-users who do not easily get sunburned. Neither the use of potassium sparing agents, nor the use of thiazides was associated with BCC.
CONCLUSION: In our study, cumulative use of high-ceiling diuretics was associated with an increased risk of diagnosis of BCC. This effect is stronger in patients who easily get sunburned. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605443     DOI: 10.1016/j.ejca.2010.04.024

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  Do Thiazide Diuretics Increase the Risk of Skin Cancer? A Critical Review of the Scientific Evidence and Updated Meta-Analysis.

Authors:  Benedetta Bendinelli; Giovanna Masala; Giuseppe Garamella; Domenico Palli; Saverio Caini
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 2.  Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.

Authors:  K Karimi; T H Lindgren; C A Koch; Robert T Brodell
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

3.  Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohort.

Authors:  Emily McDonald; D Michal Freedman; Bruce H Alexander; Michele M Doody; Margaret A Tucker; Martha S Linet; Elizabeth K Cahoon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-08       Impact factor: 4.254

4.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

5.  Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.

Authors:  Eunjung Park; Young Lee; Mihn-Sook Jue
Journal:  Korean J Intern Med       Date:  2019-12-18       Impact factor: 2.884

6.  Association Between the Use of Thiazide Diuretics and the Risk of Skin Cancers: A Meta-Analysis of Observational Studies.

Authors:  Doosup Shin; Eun Sun Lee; Joonseok Kim; Lucy Guerra; Dayan Naik; Xavier Prida
Journal:  J Clin Med Res       Date:  2019-03-18

Review 7.  Drug-induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences.

Authors:  Georg Amun Hofmann; Benedikt Weber
Journal:  J Dtsch Dermatol Ges       Date:  2021-01       Impact factor: 5.584

8.  Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.

Authors:  Sarah N Robinson; Michael S Zens; Ann E Perry; Steven K Spencer; Eric J Duell; Margaret R Karagas
Journal:  J Invest Dermatol       Date:  2013-01-23       Impact factor: 8.551

Review 9.  Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?

Authors:  Allegra Battistoni; Massimo Volpe
Journal:  Eur Cardiol       Date:  2020-04-30

10.  The frequency of photosensitizing drug dispensings in Austria and Germany: a correlation with their photosensitizing potential based on published literature.

Authors:  G A Hofmann; G Gradl; M Schulz; G Haidinger; A Tanew; B Weber
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-11-26       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.